 PARIS and CAMBRIDGE, Mass., Nov. 15, 2022 GLOBE NEWSWIRE -- NANOBIOTIX Euronext: NANO NASDAQ: NBTX the Company, a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that Laurent Levy, co-founder and chairman of the executive board, and Bart Van Rhijn, chief financial officer, will participate in a virtual fireside chat at the 5th annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022, at 9:15 AM ET 3:15 PM CET. 